We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUI icon
726
Sun Communities
SUI
$14.4B
$9K ﹤0.01%
73
– –
VOT icon
727
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20B
$9K ﹤0.01%
62
-30
-33% -$4.38K
NVTA
728
DELISTED
Invitae Corporation
NVTA
$9K ﹤0.01%
400
– –
MIME
729
DELISTED
Mimecast Limited
MIME
$9K ﹤0.01%
200
– –
DOC
730
DELISTED
PHYSICIANS REALTY TRUST
DOC
$9K ﹤0.01%
500
– –
BALL icon
731
Ball Corp
BALL
$16.4B
$8K ﹤0.01%
114
– –
EQNR icon
732
Equinor
EQNR
$97.3B
$8K ﹤0.01%
400
– –
FAF icon
733
First American
FAF
$7.38B
$8K ﹤0.01%
150
– –
GBDC icon
734
Golub Capital BDC
GBDC
$3.4B
$8K ﹤0.01%
+443
New +$7.77K
SEE
735
DELISTED
Sealed Air
SEE
$8K ﹤0.01%
176
– –
TSN icon
736
Tyson Foods
TSN
$19.6B
$8K ﹤0.01%
101
– –
AABA
737
DELISTED
Altaba Inc
AABA
$8K ﹤0.01%
120
– –
DAI
738
DELISTED
DAIMLER AG
DAI
$8K ﹤0.01%
150
– –
SIVB
739
DELISTED
SVB Financial Group
SIVB
$8K ﹤0.01%
36
+5
+16% +$1.16K
AMLP icon
740
Alerian MLP ETF
AMLP
$13.2B
$7K ﹤0.01%
+146
New +$7.22K
AUPH icon
741
Aurinia Pharmaceuticals
AUPH
$2.06B
$7K ﹤0.01%
1,000
– –
BBY icon
742
Best Buy
BBY
$17.5B
$7K ﹤0.01%
96
– –
CODI icon
743
Compass Diversified
CODI
$908M
$7K ﹤0.01%
350
– –
FFIV icon
744
F5
FFIV
$24B
$7K ﹤0.01%
46
– –
IT icon
745
Gartner
IT
$11.3B
$7K ﹤0.01%
+42
New +$6.57K
IXJ icon
746
iShares Global Healthcare ETF
IXJ
$4.23B
$7K ﹤0.01%
112
– –
LNT icon
747
Alliant Energy
LNT
$18.2B
$7K ﹤0.01%
148
+57
+63% +$2.72K
OTTR icon
748
Otter Tail
OTTR
$3.87B
$7K ﹤0.01%
134
– –
RCL icon
749
Royal Caribbean
RCL
$82.4B
$7K ﹤0.01%
57
– –
TDG icon
750
TransDigm Group
TDG
$68.3B
$7K ﹤0.01%
15
– –
28 29
30
31 32

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.